Citius Oncology
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CTOR and other ETFs, options, and stocks.About CTOR
Citius Oncology, Inc. is a biopharmaceutical company, which engages in developing and commercializing targeted oncology therapies. Its lead product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein, for the treatment of patients with persistent or recurrent CTCL, a rare form of non-Hodgkin lymphoma.
CTOR Key Statistics
Stock Snapshot
The current Citius Oncology(CTOR) stock price is $0.64, with a market capitalization of 58.72M. The stock trades at a price-to-earnings (P/E) ratio of -2.19.
During the trading session on 2026-04-11, Citius Oncology(CTOR) shares reached a daily high of $0.69 and a low of $0.64. At a current price of $0.64, the stock is 0.0% higher than the low and still -6.6% under the high.
Trading volume for Citius Oncology(CTOR) stock has reached 47.19K, versus its average volume of 199.33K.
The stock's 52-week range extends from a low of $0.49 to a high of $6.19.
The stock's 52-week range extends from a low of $0.49 to a high of $6.19.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.